Peptide Library
A structured peptide library that separates FDA-approved drugs, investigational compounds, and research-market names instead of flattening them into one hype-heavy list.
60
Profiles
13
FDA Approved
20
Investigational
27
Research Market
Browse the library
Find compounds by category, status, or name
Use quick category chips to narrow the library, or search by compound, alias, or mechanism. The page keeps the editorial category structure but collapses anything that does not match.
`FDA`, `Trials`, and `PubMed` badges are automated context indicators generated from official/public data sources. They help show whether a peptide has label, study, or literature signal, but they do not prove efficacy, safety, approval status outside the labeled context, or product quality.
⚖️
Weight Loss Peptides
17 profiles
GLP-1 agonists, dual agonists, triple agonists, and metabolic compounds tied to body-composition demand.
💪
Muscle Growth Peptides
12 profiles
Performance-adjacent peptides and growth-factor analogs that usually live outside standard medical use.
🩹
Recovery & Healing
6 profiles
Tissue-repair, soft-tissue, and gut-oriented peptides that show up constantly in injury-recovery discussions.
🧬
Anti-Aging Peptides
4 profiles
Longevity-facing compounds where mechanism, speculation, and marketing often collide.
✨
Skin & Cosmetic
6 profiles
Copper peptides, regenerative signaling compounds, and dermal-facing entries with cosmetic crossover.
📈
Growth Hormone
10 profiles
GHRH analogs and secretagogues that sit in the GH-optimization corner of the peptide market.
🧠
Nootropic Peptides
4 profiles
Cognitive and neuropeptide-oriented compounds that are popular online but often weakly explained.
🛡️
Immune & Inflammation
8 profiles
Immune-oriented peptides with more clinical framing than the average research-market profile.
🧪
Hormone Peptides
26 profiles
Hormone-linked signaling compounds that do not fit cleanly into the GH or metabolic buckets.
•
Other Peptides
6 profiles
Useful overflow for compounds that do not belong to the main editorial buckets.
⚖️ Weight Loss Peptides
Weight Loss
GLP-1 agonists, dual agonists, triple agonists, and metabolic compounds tied to body-composition demand.
17
🔥 HOT
Weight Loss
Amycretin
A Novo Nordisk investigational co-agonist targeting GLP-1 and amylin pathways, now closely watched as a next-wave obesity candidate.
Investigational 1 alias
Also in Hormone
Trials 21PubMed 14 Medium context
🔥 HOT
Weight Loss
Cagrilintide
A long-acting amylin analogue often discussed alongside GLP-1 therapies in obesity-drug development.
Investigational
Trials 40PubMed 72 Medium context
🔥 HOT
Weight Loss
CagriSema
A Novo Nordisk investigational combination of cagrilintide and semaglutide, designed to pair amylin and GLP-1 pathways in obesity.
Investigational
Also in Hormone
Trials 30PubMed 34 Medium context
🔥 HOT
Weight Loss
Eloralintide
A selective amylin receptor agonist from Eli Lilly that has moved into Phase 3 obesity trials.
Investigational 1 alias
Also in Hormone
Trials 16PubMed 5 Medium context
🔥 HOT
Weight Loss
Mazdutide
A GLP-1 and glucagon dual agonist developed with Innovent and Lilly, notable for obesity data and approval progress in China.
Investigational 2 aliases
Also in Hormone
Trials 33PubMed 40 Medium context
🔥 HOT
Weight Loss
Pemvidutide
A balanced GLP-1 and glucagon dual agonist from Altimmune with obesity and liver-disease relevance.
Investigational 1 alias
Also in Hormone
Trials 15PubMed 15 Medium context
🔥 HOT
Weight Loss
Petrelintide
A long-acting amylin analog from Zealand Pharma being developed for obesity and overweight.
Investigational
Also in Hormone
Trials 4PubMed 4 Low context
🔥 HOT
Weight Loss
Retatrutide
A next-generation triple agonist targeting GLP-1, GIP, and glucagon receptors, showing unprecedented 24.2% weight loss in clinical trials. Expected FDA approval in 2027.
Investigational 1 alias
Trials 34PubMed 138 Medium context
🔥 HOT
Weight Loss
Semaglutide
A GLP-1 receptor agonist used in FDA-approved products for type 2 diabetes, chronic weight management, and additional labeled uses depending on brand and indication.
FDA Approved 3 aliases
FDATrials 707PubMed 4.7K High context
🔥 HOT
Weight Loss
Survodutide
An investigational dual-agonist obesity and metabolic-disease candidate that shows up in next-wave incretin discussions.
Investigational
Trials 24PubMed 60 Medium context
🔥 HOT
Weight Loss
Tirzepatide
A dual GIP and GLP-1 receptor agonist used in FDA-approved products for type 2 diabetes and chronic weight management.
FDA Approved 2 aliases
FDATrials 248PubMed 2K High context
Weight Loss
AOD-9604
A modified fragment of human growth hormone discussed in weight-management and fat-metabolism circles, but not approved as an FDA drug.
Research Market 1 alias
PubMed 12 Low context
Anti-Aging
Humanin
A mitochondria-associated peptide frequently discussed in longevity circles for cytoprotective and metabolic-interest pathways.
Research Market
Also in Weight Loss
Trials 6PubMed 517 Medium context
Anti-Aging
MOTS-c
A mitochondria-derived peptide studied in metabolic and exercise-related aging discussions.
Research Market 1 alias
Also in Weight Loss
Trials 6PubMed 234 Medium context
Weight Loss
Oxyntomodulin
A gut hormone that acts on GLP-1 and glucagon-related pathways and helped shape the modern obesity-peptide conversation.
Investigational 1 alias
Also in Hormone
Trials 54PubMed 490 Medium context
Weight Loss
Peptide YY
A satiety-linked gut hormone that has long been studied in obesity and appetite regulation.
Investigational 2 aliases
Also in Hormone
Trials 699PubMed 4.3K Medium context
Weight Loss
Setmelanotide
An FDA-approved MC4R agonist marketed as Imcivree for specific rare genetic forms of obesity.
FDA Approved 2 aliases
Also in Hormone
FDATrials 29PubMed 197 High context
💪 Muscle Growth Peptides
Muscle Growth
Performance-adjacent peptides and growth-factor analogs that usually live outside standard medical use.
12
🔥 HOT
Muscle Growth
Follistatin 344
A myostatin-linked muscle-growth name that remains popular in research-market and performance discussions despite limited conventional therapeutic development.
Research Market 2 aliases
Also in Other
Trials 75PubMed 2.9K Medium context
Recovery
BPC-157
A 15-amino acid peptide derived from human gastric juice, extensively studied for tissue regeneration, gut healing, and injury recovery across multiple systems.
Research Market 2 aliases
Also in Muscle Growth
Trials 2PubMed 208 Low context
Growth Hormone
CJC-1295
A GHRH analog commonly discussed in growth-hormone optimization circles and research-market peptide stacks.
Research Market 1 alias
Also in Muscle Growth
Trials 1PubMed 30 Low context
Growth Hormone
GHRP-2
A growth hormone secretagogue that appears in older GH-optimization discussions and research-market listings.
Research Market
Also in Muscle Growth
PubMed 203 Low context
Growth Hormone
GHRP-6
A classic growth hormone secretagogue that remains common in peptide-market catalogs despite limited mainstream clinical relevance.
Research Market
Also in Muscle Growth
PubMed 632 Low context
Muscle Growth
IGF-1 DES
A truncated IGF-1 analog that remains a familiar name in performance and tissue-growth peptide discussions.
Research Market 1 alias
Also in Growth Hormone
Muscle Growth
IGF-1 LR3
A long-acting insulin-like growth factor analog discussed in physique and performance communities rather than approved peptide medicine.
Research Market 1 alias
Also in Growth Hormone
PubMed 16 Low context
Growth Hormone
Ipamorelin
A ghrelin-mimetic growth hormone secretagogue often paired with CJC-1295 in research-market discussions.
Research Market
Also in Muscle Growth
Trials 2PubMed 47 Low context
Muscle Growth
PEG-MGF
A pegylated mechano growth factor analogue often discussed in performance and recovery circles.
Research Market 2 aliases
Also in Growth Hormone
Trials 479PubMed 193 Medium context
Growth Hormone
Sermorelin
A GHRH analogue with older clinical and diagnostic history that now appears frequently in the research and wellness peptide market.
Research Market 2 aliases
Also in Muscle Growth
Trials 42PubMed 32 Medium context
Recovery
TB-500
A synthetic version of the active region of thymosin beta-4, commonly discussed for soft-tissue recovery and injury support.
Research Market 1 alias
Also in Muscle Growth
Trials 19PubMed 729 Medium context
Growth Hormone
Tesamorelin
A growth hormone-releasing hormone analog approved in the United States for reducing excess abdominal fat in certain adults with HIV-associated lipodystrophy.
FDA Approved 2 aliases
Also in Muscle Growth
FDATrials 24PubMed 87 High context
🩹 Recovery & Healing
Recovery
Tissue-repair, soft-tissue, and gut-oriented peptides that show up constantly in injury-recovery discussions.
6
Recovery
ARA-290
An erythropoietin-derived peptide fragment studied for tissue-protective and neuropathy-related applications without the red-blood-cell effects of full EPO.
Investigational 1 alias
Trials 4PubMed 77 Medium context
Recovery
BPC-157
A 15-amino acid peptide derived from human gastric juice, extensively studied for tissue regeneration, gut healing, and injury recovery across multiple systems.
Research Market 2 aliases
Also in Muscle Growth
Trials 2PubMed 208 Low context
Skin & Cosmetic
GHK-Cu
A copper-binding peptide used in cosmetic and wound-healing discussions, especially around skin appearance and tissue signaling.
Research Market 1 alias
Also in Recovery
Trials 1PubMed 78 Low context
Recovery
KPV
A short peptide fragment associated with gut-barrier, inflammatory, and tissue-soothing discussions in the peptide market.
Research Market
Also in Immune · Skin & Cosmetic
PubMed 132 Low context
Anti-Aging
SS-31
A mitochondria-targeted peptide studied for cellular energy and tissue-protection questions.
Investigational 1 alias
Also in Recovery
Trials 32PubMed 439 Medium context
Recovery
TB-500
A synthetic version of the active region of thymosin beta-4, commonly discussed for soft-tissue recovery and injury support.
Research Market 1 alias
Also in Muscle Growth
Trials 19PubMed 729 Medium context
🧬 Anti-Aging Peptides
Anti-Aging
Longevity-facing compounds where mechanism, speculation, and marketing often collide.
4
Anti-Aging
Epitalon
A short peptide associated with longevity and telomere-oriented anti-aging discussion in the research market.
Research Market 1 alias
PubMed 118 Low context
Anti-Aging
Humanin
A mitochondria-associated peptide frequently discussed in longevity circles for cytoprotective and metabolic-interest pathways.
Research Market
Also in Weight Loss
Trials 6PubMed 517 Medium context
Anti-Aging
MOTS-c
A mitochondria-derived peptide studied in metabolic and exercise-related aging discussions.
Research Market 1 alias
Also in Weight Loss
Trials 6PubMed 234 Medium context
Anti-Aging
SS-31
A mitochondria-targeted peptide studied for cellular energy and tissue-protection questions.
Investigational 1 alias
Also in Recovery
Trials 32PubMed 439 Medium context
✨ Skin & Cosmetic
Skin & Cosmetic
Copper peptides, regenerative signaling compounds, and dermal-facing entries with cosmetic crossover.
6
Skin & Cosmetic
GHK-Cu
A copper-binding peptide used in cosmetic and wound-healing discussions, especially around skin appearance and tissue signaling.
Research Market 1 alias
Also in Recovery
Trials 1PubMed 78 Low context
Recovery
KPV
A short peptide fragment associated with gut-barrier, inflammatory, and tissue-soothing discussions in the peptide market.
Research Market
Also in Immune · Skin & Cosmetic
PubMed 132 Low context
Skin & Cosmetic
Melanotan I
A melanocortin peptide analogue tied to pigmentation and photoprotection research, and closely related to the approved drug afamelanotide.
FDA Approved 2 aliases
Also in Hormone
FDATrials 23PubMed 119 High context
Skin & Cosmetic
Melanotan II
A melanocortin analogue commonly discussed for tanning and cosmetic interest but not approved as an FDA drug.
Research Market
Also in Hormone
Trials 1PubMed 197 Low context
Hormone
PT-141
A melanocortin peptide best known in regulated medicine as bremelanotide and in the research market as PT-141.
FDA Approved 2 aliases
Also in Skin & Cosmetic
FDATrials 10PubMed 107 High context
Skin & Cosmetic
SNAP-8
A cosmetic-facing peptide often discussed in topical anti-wrinkle and expression-line products.
Research Market 1 alias
📈 Growth Hormone
Growth Hormone
GHRH analogs and secretagogues that sit in the GH-optimization corner of the peptide market.
10
Growth Hormone
CJC-1295
A GHRH analog commonly discussed in growth-hormone optimization circles and research-market peptide stacks.
Research Market 1 alias
Also in Muscle Growth
Trials 1PubMed 30 Low context
Growth Hormone
GHRP-2
A growth hormone secretagogue that appears in older GH-optimization discussions and research-market listings.
Research Market
Also in Muscle Growth
PubMed 203 Low context
Growth Hormone
GHRP-6
A classic growth hormone secretagogue that remains common in peptide-market catalogs despite limited mainstream clinical relevance.
Research Market
Also in Muscle Growth
PubMed 632 Low context
Growth Hormone
Hexarelin
A growth hormone secretagogue and ghrelin-receptor agonist that remains a familiar legacy name in GH-peptide stacks.
Research Market
Also in Hormone
PubMed 288 Low context
Muscle Growth
IGF-1 DES
A truncated IGF-1 analog that remains a familiar name in performance and tissue-growth peptide discussions.
Research Market 1 alias
Also in Growth Hormone
Muscle Growth
IGF-1 LR3
A long-acting insulin-like growth factor analog discussed in physique and performance communities rather than approved peptide medicine.
Research Market 1 alias
Also in Growth Hormone
PubMed 16 Low context
Growth Hormone
Ipamorelin
A ghrelin-mimetic growth hormone secretagogue often paired with CJC-1295 in research-market discussions.
Research Market
Also in Muscle Growth
Trials 2PubMed 47 Low context
Muscle Growth
PEG-MGF
A pegylated mechano growth factor analogue often discussed in performance and recovery circles.
Research Market 2 aliases
Also in Growth Hormone
Trials 479PubMed 193 Medium context
Growth Hormone
Sermorelin
A GHRH analogue with older clinical and diagnostic history that now appears frequently in the research and wellness peptide market.
Research Market 2 aliases
Also in Muscle Growth
Trials 42PubMed 32 Medium context
Growth Hormone
Tesamorelin
A growth hormone-releasing hormone analog approved in the United States for reducing excess abdominal fat in certain adults with HIV-associated lipodystrophy.
FDA Approved 2 aliases
Also in Muscle Growth
FDATrials 24PubMed 87 High context
🧠 Nootropic Peptides
Nootropic
Cognitive and neuropeptide-oriented compounds that are popular online but often weakly explained.
4
🔥 HOT
Nootropic
Dihexa
A high-curiosity neurotrophic research peptide discussed for cognition and synaptogenesis, but still lacking real clinical development.
Research Market 2 aliases
Also in Other
PubMed 17 Low context
Nootropic
DSIP
A peptide discussed for sleep-related and neuroregulatory interest, though its evidence base is far less concrete than vendor listings suggest.
Research Market 1 alias
PubMed 462 Low context
Nootropic
Selank
A synthetic peptide associated with anxiolytic and cognitive-interest discussions in nootropic communities.
Research Market
Also in Immune
Trials 10PubMed 68 Medium context
Nootropic
Semax
A synthetic neuropeptide analog often discussed for cognitive and neuroprotection-related interest in research-market circles.
Research Market
Also in Immune
PubMed 397 Low context
🛡️ Immune & Inflammation
Immune
Immune-oriented peptides with more clinical framing than the average research-market profile.
8
Other
Cortistatin
A neuropeptide related to somatostatin that has been studied for anti-inflammatory, neuroendocrine, and cardiovascular effects.
Investigational 1 alias
Also in Hormone · Immune
Trials 712 Low context
Recovery
KPV
A short peptide fragment associated with gut-barrier, inflammatory, and tissue-soothing discussions in the peptide market.
Research Market
Also in Immune · Skin & Cosmetic
PubMed 132 Low context
Immune
LL-37
A host-defense peptide associated with innate immunity and tissue-response discussions.
Research Market
Trials 98PubMed 4.2K Medium context
Nootropic
Selank
A synthetic peptide associated with anxiolytic and cognitive-interest discussions in nootropic communities.
Research Market
Also in Immune
Trials 10PubMed 68 Medium context
Nootropic
Semax
A synthetic neuropeptide analog often discussed for cognitive and neuroprotection-related interest in research-market circles.
Research Market
Also in Immune
PubMed 397 Low context
Immune
Thymalin
A thymus-derived peptide complex often discussed in immune and longevity circles.
Research Market
PubMed 234 Low context
Immune
Thymosin Alpha-1
An immune-oriented peptide discussed for immunomodulatory signaling and clinical research in infectious disease and oncology-adjacent contexts.
Investigational 2 aliases
Trials 76PubMed 1.3K Medium context
Immune
VIP
A vasoactive intestinal peptide associated with neuroimmune and inflammatory signaling discussions.
Investigational 1 alias
Trials 53PubMed 1K Medium context
🧪 Hormone Peptides
Hormone
Hormone-linked signaling compounds that do not fit cleanly into the GH or metabolic buckets.
26
🔥 HOT
Weight Loss
Amycretin
A Novo Nordisk investigational co-agonist targeting GLP-1 and amylin pathways, now closely watched as a next-wave obesity candidate.
Investigational 1 alias
Also in Hormone
Trials 21PubMed 14 Medium context
🔥 HOT
Other
Brenipatide
A Lilly investigational peptide candidate being studied in alcohol use disorder, mood disorders, and other craving-linked conditions.
Investigational 1 alias
Also in Hormone
Trials 16 Low context
🔥 HOT
Weight Loss
CagriSema
A Novo Nordisk investigational combination of cagrilintide and semaglutide, designed to pair amylin and GLP-1 pathways in obesity.
Investigational
Also in Hormone
Trials 30PubMed 34 Medium context
🔥 HOT
Weight Loss
Eloralintide
A selective amylin receptor agonist from Eli Lilly that has moved into Phase 3 obesity trials.
Investigational 1 alias
Also in Hormone
Trials 16PubMed 5 Medium context
🔥 HOT
Weight Loss
Mazdutide
A GLP-1 and glucagon dual agonist developed with Innovent and Lilly, notable for obesity data and approval progress in China.
Investigational 2 aliases
Also in Hormone
Trials 33PubMed 40 Medium context
🔥 HOT
Weight Loss
Pemvidutide
A balanced GLP-1 and glucagon dual agonist from Altimmune with obesity and liver-disease relevance.
Investigational 1 alias
Also in Hormone
Trials 15PubMed 15 Medium context
🔥 HOT
Weight Loss
Petrelintide
A long-acting amylin analog from Zealand Pharma being developed for obesity and overweight.
Investigational
Also in Hormone
Trials 4PubMed 4 Low context
Hormone
Apelin
An endogenous peptide ligand for the APJ receptor with cardiovascular and metabolic research relevance.
Investigational
Also in Other
Trials 64PubMed 2.9K Medium context
Hormone
Avexitide
A GLP-1 receptor antagonist, also known as exendin 9-39, now in Phase 3 for post-bariatric hypoglycemia.
Investigational 1 alias
Also in Other
Trials 56PubMed 524 Medium context
Other
Cortistatin
A neuropeptide related to somatostatin that has been studied for anti-inflammatory, neuroendocrine, and cardiovascular effects.
Investigational 1 alias
Also in Hormone · Immune
Trials 712 Low context
Hormone
Dasiglucagon
A glucagon analog approved in the United States as Zegalogue for severe hypoglycemia.
FDA Approved 1 alias
FDATrials 21 Medium context
Hormone
Gonadorelin
A GnRH analogue tied to endocrine signaling, diagnostic history, and fertility-related peptide discussions.
Research Market 2 aliases
Trials 150PubMed 293 Medium context
Growth Hormone
Hexarelin
A growth hormone secretagogue and ghrelin-receptor agonist that remains a familiar legacy name in GH-peptide stacks.
Research Market
Also in Hormone
PubMed 288 Low context
Hormone
Kisspeptin
A reproductive-axis signaling peptide studied for its role in GnRH release and fertility-related endocrinology.
Investigational
Trials 45PubMed 3.2K Medium context
Hormone
Lanreotide
A long-acting somatostatin analog marketed as Somatuline Depot and used in neuroendocrine and acromegaly-related care.
FDA Approved 2 aliases
FDATrials 124PubMed 1.2K High context
Skin & Cosmetic
Melanotan I
A melanocortin peptide analogue tied to pigmentation and photoprotection research, and closely related to the approved drug afamelanotide.
FDA Approved 2 aliases
Also in Hormone
FDATrials 23PubMed 119 High context
Skin & Cosmetic
Melanotan II
A melanocortin analogue commonly discussed for tanning and cosmetic interest but not approved as an FDA drug.
Research Market
Also in Hormone
Trials 1PubMed 197 Low context
Hormone
Metreleptin
An FDA-approved leptin analog used in rare metabolic disease, best known in the United States as Myalept.
FDA Approved 1 alias
FDATrials 41PubMed 244 High context
Hormone
Octreotide
A somatostatin analog widely used in endocrine and neuroendocrine medicine, and one of the most important approved peptide drugs missing from many peptide libraries.
FDA Approved 2 aliases
FDATrials 375 Medium context
Weight Loss
Oxyntomodulin
A gut hormone that acts on GLP-1 and glucagon-related pathways and helped shape the modern obesity-peptide conversation.
Investigational 1 alias
Also in Hormone
Trials 54PubMed 490 Medium context
Hormone
Oxytocin
A peptide hormone used in FDA-approved medical settings but also frequently reframed in wellness and research-market discussions.
FDA Approved 1 alias
FDATrials 1.4KPubMed 29.1K High context
Hormone
Pasireotide
An FDA-approved somatostatin analog marketed as Signifor, used in Cushing's disease and related endocrine settings.
FDA Approved 2 aliases
FDATrials 87PubMed 751 High context
Weight Loss
Peptide YY
A satiety-linked gut hormone that has long been studied in obesity and appetite regulation.
Investigational 2 aliases
Also in Hormone
Trials 699PubMed 4.3K Medium context
Hormone
PT-141
A melanocortin peptide best known in regulated medicine as bremelanotide and in the research market as PT-141.
FDA Approved 2 aliases
Also in Skin & Cosmetic
FDATrials 10PubMed 107 High context
Weight Loss
Setmelanotide
An FDA-approved MC4R agonist marketed as Imcivree for specific rare genetic forms of obesity.
FDA Approved 2 aliases
Also in Hormone
FDATrials 29PubMed 197 High context
Hormone
Vosoritide
An FDA-approved C-type natriuretic peptide analog marketed as Voxzogo for achondroplasia.
FDA Approved 1 alias
FDATrials 18PubMed 100 High context
• Other Peptides
Other
Useful overflow for compounds that do not belong to the main editorial buckets.
6
🔥 HOT
Other
Brenipatide
A Lilly investigational peptide candidate being studied in alcohol use disorder, mood disorders, and other craving-linked conditions.
Investigational 1 alias
Also in Hormone
Trials 16 Low context
🔥 HOT
Nootropic
Dihexa
A high-curiosity neurotrophic research peptide discussed for cognition and synaptogenesis, but still lacking real clinical development.
Research Market 2 aliases
Also in Other
PubMed 17 Low context
🔥 HOT
Muscle Growth
Follistatin 344
A myostatin-linked muscle-growth name that remains popular in research-market and performance discussions despite limited conventional therapeutic development.
Research Market 2 aliases
Also in Other
Trials 75PubMed 2.9K Medium context
Hormone
Apelin
An endogenous peptide ligand for the APJ receptor with cardiovascular and metabolic research relevance.
Investigational
Also in Other
Trials 64PubMed 2.9K Medium context
Hormone
Avexitide
A GLP-1 receptor antagonist, also known as exendin 9-39, now in Phase 3 for post-bariatric hypoglycemia.
Investigational 1 alias
Also in Other
Trials 56PubMed 524 Medium context
Other
Cortistatin
A neuropeptide related to somatostatin that has been studied for anti-inflammatory, neuroendocrine, and cardiovascular effects.
Investigational 1 alias
Also in Hormone · Immune
Trials 712 Low context
No peptide profiles match that filter yet.
Try a broader category, clear the search, or switch back to all statuses.